Description
TREN AE MIX 100
- Trenbolone Acetate 50mg/ml
- Trenbolone Enanthate 50mg/ml
TREN AE MIX 100 combines 50mg/ml of Trenbolone Acetate with 50mg/ml of Trenbolone Enanthate, delivering a unique hybrid solution that merges rapid onset with sustained activity. Designed for users seeking both fast-acting strength gains and long-term anabolic effects, this blend provides consistent power, density, and metabolic efficiency.
The Acetate component offers immediate physiological response, noticeable in the early phase of the cycle, while the Enanthate ensures prolonged stability and extended performance benefits. This synergy supports lean mass development, fat reduction, and unmatched muscular hardness without water retention.
Application:
Recommended for intermediate to advanced users aiming to maximize performance with fewer injections compared to short esters alone. Often used in 8–10 week cycles for athletes seeking adaptable results with aggressive muscle definition and strength output.
Important Note:
Due to the dual-ester structure, blood levels remain more stable compared to acetate-only protocols. However, the compound’s potency demands proper cycle support, monitoring of cardiovascular markers, and a structured post-cycle recovery.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.